Helio Health Group, LLC (“HELIO” or the “Company”), a specialized expert-driven Artificial Intelligence (AI) company focused on the life sciences industry, announces that it has received a strategic minority investment from WestView Capital Partners (“WestView”), a Boston-based growth equity firm focused exclusively on partnering with middle market growth companies. Founded to serve the increasingly complex needs of pharmaceutical, biotechnology, and broader life sciences companies, HELIO provides deep expertise across the industry. The Company has built a differentiated model that combines deep industry expertise with practical execution and advanced AI capabilities.
Read the full article: Helio Health Group Announces Strategic Minority Investment from WestView Capital Partners to Accelerate Growth //
Source: https://wvcapital.com/news/helio-health-group-announces-strategic-minority-investment-from-westview-capital-partners-to-accelerate-growth